NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis $2.83 +0.06 (+2.17%) Closing price 06/23/2025 03:55 PM EasternExtended Trading$3.02 +0.19 (+6.57%) As of 08:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About IM Cannabis Stock (NASDAQ:IMCC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IM Cannabis alerts:Sign Up Key Stats Today's Range$2.62▼$3.3550-Day Range$1.46▼$5.2252-Week Range$1.29▼$7.12Volume143,861 shsAverage Volume93,537 shsMarket Capitalization$6.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More… IM Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreIMCC MarketRank™: IM Cannabis scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for IM Cannabis. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -4.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -4.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIM Cannabis has a P/B Ratio of 2.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about IM Cannabis' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.70% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently increased by 852.17%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.70% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently increased by 852.17%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News SentimentN/A Search Interest4 people have searched for IMCC on MarketBeat in the last 30 days. MarketBeat Follows4 people have added IM Cannabis to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address IMCC Stock News HeadlinesIM Cannabis (NASDAQ:IMCC) Stock, Earnings Estimates, EPS, And RevenueJune 1, 2025 | benzinga.comIM Cannabis Stock Price, Quotes and Forecasts | NASDAQ:IMCC | BenzingaJune 1, 2025 | benzinga.comHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.June 24, 2025 | Brownstone Research (Ad)IM Cannabis Corp.: IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities ExchangeMay 28, 2025 | finanznachrichten.deIM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities ExchangeMay 28, 2025 | prnewswire.comIM Cannabis Provides Corporate UpdatesMay 27, 2025 | prnewswire.comIM Cannabis Corp. (IMCC) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comIM Cannabis Reports First Quarter Financial ResultsMay 15, 2025 | prnewswire.comSee More Headlines IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed this year? IM Cannabis' stock was trading at $2.33 at the start of the year. Since then, IMCC shares have increased by 21.5% and is now trading at $2.83. View the best growth stocks for 2025 here. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) released its quarterly earnings results on Thursday, May, 15th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.25) by $0.31. The business earned $8.69 million during the quarter, compared to analyst estimates of $11.45 million. IM Cannabis had a negative net margin of 9.10% and a negative trailing twelve-month return on equity of 122.96%. Read the conference call transcript. When did IM Cannabis' stock split? IM Cannabis's stock reverse split on Friday, July 12th 2024.The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IM Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), GE Aerospace (GE) and AppLovin (APP). Company Calendar Last Earnings5/15/2025Today6/24/2025Next Earnings (Estimated)8/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:IMCC CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees340Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.72 million Net Margins-9.10% Pretax Margin-11.97% Return on Equity-122.96% Return on Assets-11.69% Debt Debt-to-Equity Ratio0.10 Current Ratio0.72 Quick Ratio0.59 Sales & Book Value Annual Sales$39.44 million Price / Sales0.16 Cash FlowN/A Price / Cash FlowN/A Book Value$1.03 per share Price / Book2.75Miscellaneous Outstanding Shares2,230,000Free FloatN/AMarket Cap$6.31 million OptionableNot Optionable Beta2.43 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:IMCC) was last updated on 6/24/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | Sponsored12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.